Funding Opportunities: 

Healthcare/Medtech

​The EIC Accelerator is a European funding programme under Horizon Europe that supports start-ups and SMEs developing innovative, game-changing products, services, or business models with the potential to create new markets or disrupt existing ones. It offers grant funding of up to €2.5 million for innovation activities (TRL 6-8) and equity investments ranging from €0.5 to €10 million, with higher amounts available under the STEP ScaleUp scheme.

This funding opportunity provides loans of £100,000 to £5 million for late-stage R&D projects by UK-registered SMEs. It targets highly innovative projects with clear commercialisation routes and significant economic impact, especially in future economy areas highlighted by Innovate UK. Applicants must show a need for public funding, the ability to repay loans, and a credible repayment plan. Eligible projects should deliver new or significantly improved products, processes, or services and fall within key areas such as Net Zero (energy, industrial processes, agriculture, food, capital intensity), Health and Wellbeing (ill health, wellbeing, diet, food), and Next Generation Digital and Technology Families (AI, advanced computing, bioinformatics, genomics, robotics, smart machines, advanced materials, quantum, energy and environment technologies). Funding is awarded competitively across multiple rounds, with project durations of up to five years covering both R&D and commercialisation phases.

This competition funds business-led collaborative research and development projects focused on industrial research between the UK, Japan, and other Eureka participating countries, with Innovate UK supporting the UK partners only. Projects must demonstrate strong market potential and aim to develop innovative products, technology-based applications, or services that involve technological risk and represent a substantial advancement beyond incremental improvements. Funding will not be provided for projects involving non-civilian technologies, work in the nuclear or drug discovery sectors, or those lacking at least one UK-registered business and one eligible Japanese partner.

We are interested in funding high quality applied health and social care research to increase and improve the evidence base about early action and prevention with health and social care services. Innovation that could facilitate a marked change in how we deal with complex health issues.

We are looking to fund research which has the potential to inform prevention services at a national level, and therefore local or regional evaluations are unlikely to be fundable. Similarly, evaluations focused on emerging technologies will require evidence of readiness for research on large-scale service delivery, including the published evidence base. All research should consider health and/or social care inequalities, or research focusing on how reducing inequalities can be integrated into prevention services. Alongside this, increasing access to neighbourhood health and social care services, moving care from hospitals into the community, and/or avoiding hospital admissions in the context of prevention are of particular interest to HSDR.

‍

This pilot aims to accelerate high-risk deep tech innovation by supporting breakthrough solutions in areas where commercial uptake is limited, while testing whether stage-gated funding and early involvement of end-users improve market adoption. It focuses on two major challenges: Physical AI for next-generation robotics, and New Approach Methodologies that can replace or reduce animal testing in biomedical research and product safety. Eligible applicants include start-ups, SMEs, and research organisations, with funding delivered across two stages to develop, validate, and test solutions in real-world settings. Successful projects can receive up to €300,000 in Stage 1 and up to €2.5 million in Stage 2, alongside access to partners, experts, and a wider innovation ecosystem.

Innovate UK Growth Catalyst is a program that supports high-potential UK startups and scaleups by combining grant funding of up to £900k per company with aligned private investment and structured growth support. It targets late-stage innovation across key sectors—including advanced manufacturing, clean energy, creative industries, defence and security, digital technologies, life sciences and foundation industries—and requires applicants to have confirmed backing from an approved Innovate UK Investor Partner. Projects may involve feasibility studies, industrial research or experimental development, each with specific funding and match-investment requirements, with awards made competitively to those best aligned with Innovate UK’s strategic objectives.

The NIHR Decarbonising the Health and Social Care System fund supports UK research that reduces carbon emissions and promotes sustainability in health and social care. With £25 million available over five years, it backs projects developing or evaluating innovations, service models, or care pathways that advance net zero goals and can inform policy and practice. Open to UK-based researchers and organisations, the programme encourages collaboration with SMEs, charities, and local authorities to deliver practical, scalable solutions.

‍

This funding opportunity supports high-quality applied health and social care research focused on early action, prevention, and reducing inequalities at a national level. It aims to generate evidence that improves prevention services, enhances access to community-based care, and reduces hospital admissions. Research should address preventative strategies, early diagnosis, and interventions for those at risk of long-term conditions, demonstrating clear national impact and relevance to the NHS and social care. Areas of interest include improving prevention pathways, integrating preventative approaches, using data to deliver proactive support, and evaluating innovative service models or technologies. There are no specific eligibility restrictions for applicants.

‍